{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:09:45Z","timestamp":1761844185375},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00383-012-3086-6","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T13:30:27Z","timestamp":1334669427000},"page":"579-589","source":"Crossref","is-referenced-by-count":6,"title":["In vitro evaluation of the Aurora kinase inhibitor VX-680 for Hepatoblastoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Alexander","family":"Dewerth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Wonner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justus","family":"Lieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Ellerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Warmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Armeanu-Ebinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"issue":"11","key":"3086_CR1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","volume":"36","author":"J Brown","year":"2000","unstructured":"Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P et al (2000) Pretreatment prognostic factors for children with hepatoblastoma\u2013 results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36(11):1418\u20131425","journal-title":"Eur J Cancer"},{"issue":"4","key":"3086_CR2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/oxfordjournals.bmb.a011577","volume":"52","author":"CA Stiller","year":"1996","unstructured":"Stiller CA, Parkin DM (1996) Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 52(4):682\u2013703","journal-title":"Br Med Bull"},{"issue":"15","key":"3086_CR3","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","volume":"28","author":"J Zsiros","year":"2010","unstructured":"Zsiros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P et al (2010) Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 28(15):2584\u20132590","journal-title":"J Clin Oncol"},{"issue":"2","key":"3086_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpedsurg.2008.10.088","volume":"44","author":"T Oue","year":"2009","unstructured":"Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M (2009) Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies. J Pediatr Surg 44(2):377\u2013380","journal-title":"J Pediatr Surg"},{"issue":"8","key":"3086_CR5","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.10858","volume":"95","author":"S Warmann","year":"2002","unstructured":"Warmann S, Hunger M, Teichmann B, Flemming P, Gratz KF, Fuchs J (2002) The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model. Cancer 95(8):1795\u20131801","journal-title":"Cancer"},{"issue":"7015","key":"3086_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","volume":"432","author":"C Sawyers","year":"2004","unstructured":"Sawyers C (2004) Targeted cancer therapy. Nature 432(7015):294\u2013297","journal-title":"Nature"},{"issue":"6","key":"3086_CR7","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/1078-0432.CCR-07-2179","volume":"14","author":"O Gautschi","year":"2008","unstructured":"Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN Jr, Gandara DR (2008) Aurora kinases as anticancer drug targets. Clin Cancer Res 14(6):1639\u20131648","journal-title":"Clin Cancer Res"},{"issue":"13","key":"3086_CR8","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/jnci\/91.13.1160","volume":"91","author":"H Katayama","year":"1999","unstructured":"Katayama H, Ota T, Jisaki F, Ueda Y, Tanaka T, Odashima S et al (1999) Mitotic kinase expression and colorectal cancer progression. J Natl Cancer Inst 91(13):1160\u20131162","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"3086_CR9","first-page":"4811","volume":"58","author":"M Tatsuka","year":"1998","unstructured":"Tatsuka M, Katayama H, Ota T, Tanaka T, Odashima S, Suzuki F et al (1998) Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 58(21):4811\u20134816","journal-title":"Cancer Res"},{"issue":"1","key":"3086_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.MCR-06-0208","volume":"5","author":"J Fu","year":"2007","unstructured":"Fu J, Bian M, Jiang Q, Zhang C (2007) Roles of aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 5(1):1\u201310","journal-title":"Mol Cancer Res"},{"issue":"3","key":"3086_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm1003","volume":"10","author":"EA Harrington","year":"2004","unstructured":"Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T et al (2004) VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 10(3):262\u2013267","journal-title":"Nat Med"},{"issue":"1","key":"3086_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/j.1460-2075.1993.tb05633.x","volume":"12","author":"CH McGowan","year":"1993","unstructured":"McGowan CH, Russell P (1993) Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J 12(1):75\u201385","journal-title":"EMBO J"},{"issue":"3","key":"3086_CR13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/emboj\/16.3.545","volume":"16","author":"MJ O\u2019Connell","year":"1997","unstructured":"O\u2019Connell MJ, Raleigh JM, Verkade HM, Nurse P (1997) Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 16(3):545\u2013554","journal-title":"EMBO J"},{"issue":"13","key":"3086_CR14","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-10-2537","volume":"17","author":"PC Witt Hamer De","year":"2011","unstructured":"De Witt Hamer PC, Mir SE, Noske D, Van Noorden CJ, Wurdinger T (2011) WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe. Clin Cancer Res 17(13):4200\u20134207","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3086_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molcel.2006.06.017","volume":"23","author":"AL Clayton","year":"2006","unstructured":"Clayton AL, Hazzalin CA, Mahadevan LC (2006) Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23(3):289\u2013296","journal-title":"Mol Cell"},{"issue":"12","key":"3086_CR16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1349-7006.2001.tb02153.x","volume":"92","author":"JH Choi","year":"2001","unstructured":"Choi JH, Kwon HJ, Yoon BI, Kim JH, Han SU, Joo HJ et al (2001) Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res 92(12):1300\u20131304","journal-title":"Jpn J Cancer Res"},{"issue":"2","key":"3086_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.20022","volume":"59","author":"K Halkidou","year":"2004","unstructured":"Halkidou K, Gaughan L, Cook S, Leung HY, Neal DE, Robson CN (2004) Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59(2):177\u2013189","journal-title":"Prostate"},{"issue":"12","key":"3086_CR18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1517\/13543784.14.12.1497","volume":"14","author":"PA Marks","year":"2005","unstructured":"Marks PA, Dokmanovic M (2005) Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs 14(12):1497\u20131511","journal-title":"Expert Opin Investig Drugs"},{"key":"3086_CR19","doi-asserted-by":"crossref","first-page":"830260","DOI":"10.1155\/2011\/830260","volume":"2011","author":"H Rikiishi","year":"2011","unstructured":"Rikiishi H (2011) Autophagic and apoptotic effects of HDAC inhibitors on cancer cells. J Biomed Biotechnol 2011:830260","journal-title":"J Biomed Biotechnol"},{"issue":"12","key":"3086_CR20","first-page":"1273","volume":"2","author":"RR Rosato","year":"2003","unstructured":"Rosato RR, Almenara JA, Dai Y, Grant S (2003) Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. Mol Cancer Ther 2(12):1273\u20131284","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3086_CR21","first-page":"1","volume":"67","author":"I Doi","year":"1976","unstructured":"Doi I (1976) Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gann 67(1):1\u201310","journal-title":"Gann"},{"issue":"4","key":"3086_CR22","first-page":"809","volume":"74","author":"T Pietsch","year":"1996","unstructured":"Pietsch T, Fonatsch C, Albrecht S, Maschek H, Wolf HK, Von SD (1996) Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. Lab Invest 74(4):809\u2013818","journal-title":"Lab Invest"},{"issue":"2","key":"3086_CR23","first-page":"447","volume":"38","author":"C Eicher","year":"2011","unstructured":"Eicher C, Dewerth A, Kirchner B, Warmann SW, Fuchs J, Armeanu-Ebinger S (2011) Development of a drug resistance model for hepatoblastoma. Int J Oncol 38(2):447\u2013454","journal-title":"Int J Oncol"},{"issue":"2","key":"3086_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00383-011-2988-z","volume":"28","author":"J Lieber","year":"2012","unstructured":"Lieber J, Ellerkamp V, Wenz J, Kirchner B, Warmann SW, Fuchs J et al (2012) Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells. Pediatr Surg Int 28(2):149\u2013159","journal-title":"Pediatr Surg Int"},{"issue":"4","key":"3086_CR25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1478-3231.2011.02729.x","volume":"32","author":"C Eicher","year":"2012","unstructured":"Eicher C, Dewerth A, Kirchner B, Warmann SW, Fuchs J, Armeanu-Ebinger S (2012) Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1(nu) mice. Liver Int 32(4):574\u2013581","journal-title":"Liver Int"},{"issue":"6","key":"3086_CR26","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/1078-0432.CCR-1057-03","volume":"10","author":"YM Jeng","year":"2004","unstructured":"Jeng YM, Peng SY, Lin CY, Hsu HC (2004) Overexpression and amplification of aurora-A in hepatocellular carcinoma. Clin Cancer Res 10(6):2065\u20132071","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3086_CR27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/jhep.2003.50112","volume":"37","author":"T Masaki","year":"2003","unstructured":"Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K et al (2003) Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37(3):534\u2013543","journal-title":"Hepatology"},{"issue":"5","key":"3086_CR28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.153.5.1023","volume":"153","author":"R Wang","year":"2001","unstructured":"Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM (2001) Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 153(5):1023\u20131034","journal-title":"J Cell Biol"},{"issue":"4","key":"3086_CR29","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/0008-5472.CAN-06-2272","volume":"67","author":"P Briassouli","year":"2007","unstructured":"Briassouli P, Chan F, Savage K, Reis-Filho JS, Linardopoulos S (2007) Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of I\u00a0kappa B\u00a0alpha. Cancer Res 67(4):1689\u20131695","journal-title":"Cancer Res"},{"issue":"19","key":"3086_CR30","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1158\/1078-0432.CCR-08-0721","volume":"14","author":"W Fiskus","year":"2008","unstructured":"Fiskus W, Wang Y, Joshi R, Rao R, Yang Y, Chen J et al (2008) Co-treatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells. Clin Cancer Res 14(19):6106\u20136115","journal-title":"Clin Cancer Res"},{"issue":"18","key":"3086_CR31","first-page":"5165","volume":"60","author":"LM Butler","year":"2000","unstructured":"Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C et al (2000) Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60(18):5165\u20135170","journal-title":"Cancer Res"},{"issue":"4","key":"3086_CR32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1023768811842","volume":"22","author":"PC Ma","year":"2003","unstructured":"Ma PC, Maulik G, Christensen J, Salgia R (2003) c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev 22(4):309\u2013325","journal-title":"Cancer Metastasis Rev"},{"issue":"6248","key":"3086_CR33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/342440a0","volume":"342","author":"T Nakamura","year":"1989","unstructured":"Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A et al (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342(6248):440\u2013443","journal-title":"Nature"},{"issue":"12","key":"3086_CR34","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/1078-0432.CCR-06-0818","volume":"12","author":"B Peruzzi","year":"2006","unstructured":"Peruzzi B, Bottaro DP (2006) Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12(12):3657\u20133660","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3086_CR35","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/hep.510250413","volume":"25","author":"T Ueki","year":"1997","unstructured":"Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E (1997) Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25(4):862\u2013866","journal-title":"Hepatology"},{"key":"3086_CR36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1479-5876-9-64","volume":"9","author":"J Hou","year":"2011","unstructured":"Hou J, Dong J, Sun L, Geng L, Wang J, Zheng J et al (2011) Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274. J Transl Med 9:64","journal-title":"J Transl Med"},{"issue":"2","key":"3086_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5582\/bst.2011.v5.2.52","volume":"5","author":"Y Inagaki","year":"2011","unstructured":"Inagaki Y, Qi F, Gao J, Qu X, Hasegawa K, Sugawara Y et al (2011) Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth. Biosci Trends 5(2):52\u201356","journal-title":"Biosci Trends"},{"issue":"9","key":"3086_CR38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/onc.2010.490","volume":"30","author":"VW Lui","year":"2011","unstructured":"Lui VW, Wong EY, Ho K, Ng PK, Lau CP, Tsui SK et al (2011) Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death. Oncogene 30(9):1127\u20131134","journal-title":"Oncogene"},{"issue":"2","key":"3086_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2<151::AID-IJC1>3.0.CO;2-6","volume":"85","author":"SD Von","year":"2000","unstructured":"Von SD, Faundez A, Teichmann B, Birnbaum T, Koch A, Hecker H et al (2000) Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer 85(2):151\u2013159","journal-title":"Int J Cancer"},{"issue":"4","key":"3086_CR40","doi-asserted-by":"crossref","first-page":"e5120","DOI":"10.1371\/journal.pone.0005120","volume":"4","author":"E Iorns","year":"2009","unstructured":"Iorns E, Lord CJ, Grigoriadis A, McDonald S, Fenwick K, Mackay A et al (2009) Integrated functional, gene expression and genomic analysis for the identification of cancer targets. PLoS ONE 4(4):e5120","journal-title":"PLoS ONE"},{"issue":"3","key":"3086_CR41","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","volume":"22","author":"C Crosio","year":"2002","unstructured":"Crosio C, Fimia GM, Loury R, Kimura M, Okano Y, Zhou H et al (2002) Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian aurora kinases. Mol Cell Biol 22(3):874\u2013885","journal-title":"Mol Cell Biol"},{"issue":"3","key":"3086_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8674(00)00034-9","volume":"102","author":"JY Hsu","year":"2000","unstructured":"Hsu JY, Sun ZW, Li X, Reuben M, Tatchell K, Bishop DK et al (2000) Mitotic phosphorylation of histone H3 is governed by Ipl1\/aurora kinase and Glc7\/PP1 phosphatase in budding yeast and nematodes. Cell 102(3):279\u2013291","journal-title":"Cell"},{"issue":"1","key":"3086_CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jss.2007.03.054","volume":"144","author":"SW Warmann","year":"2008","unstructured":"Warmann SW, Frank H, Heitmann H, Ruck P, Herberts T, Seitz G et al (2008) Bcl-2 gene silencing in pediatric epithelial liver tumors. J Surg Res 144(1):43\u201348","journal-title":"J Surg Res"},{"issue":"15","key":"3086_CR44","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-05-3353","volume":"66","author":"F Gizatullin","year":"2006","unstructured":"Gizatullin F, Yao Y, Kung V, Harding MW, Loda M, Shapiro GI (2006) The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 66(15):7668\u20137677","journal-title":"Cancer Res"},{"issue":"1","key":"3086_CR45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pbc.22465","volume":"55","author":"A El-Sheikh","year":"2010","unstructured":"El-Sheikh A, Fan R, Birks D, Donson A, Foreman NK, Vibhakar R (2010) Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines. Pediatr Blood Cancer 55(1):35\u201341","journal-title":"Pediatr Blood Cancer"},{"issue":"47","key":"3086_CR46","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22(47):7265\u20137279","journal-title":"Oncogene"},{"issue":"22","key":"3086_CR47","first-page":"5019","volume":"58","author":"X Wang","year":"1998","unstructured":"Wang X, Wong SC, Pan J, Tsao SW, Fung KH, Kwong DL et al (1998) Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Cancer Res 58(22):5019\u20135022","journal-title":"Cancer Res"},{"issue":"6","key":"3086_CR48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1097-2765(00)80256-7","volume":"5","author":"P Cheung","year":"2000","unstructured":"Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD (2000) Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 5(6):905\u2013915","journal-title":"Mol Cell"},{"issue":"19","key":"3086_CR49","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1158\/1078-0432.CCR-08-0721","volume":"14","author":"W Fiskus","year":"2008","unstructured":"Fiskus W, Wang Y, Joshi R, Rao R, Yang Y, Chen J et al (2008) Co-treatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells. Clin Cancer Res 14(19):6106\u20136115","journal-title":"Clin Cancer Res"},{"key":"3086_CR50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1755-8794-2-67","volume":"2","author":"MJ LaBonte","year":"2009","unstructured":"LaBonte MJ, Wilson PM, Fazzone W, Groshen S, Lenz HJ, Ladner RD (2009) DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines. BMC Med Genomics 2:67","journal-title":"BMC Med Genomics"},{"issue":"13","key":"3086_CR51","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1158\/1078-0432.CCR-05-1964","volume":"12","author":"C Soncini","year":"2006","unstructured":"Soncini C, Carpinelli P, Gianellini L, Fancelli D, Vianello P, Rusconi L et al (2006) PHA-680632, a novel aurora kinase inhibitor with potent antitumoral activity. Clin Cancer Res 12(13):4080\u20134089","journal-title":"Clin Cancer Res"},{"issue":"22","key":"3086_CR52","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2174\/0929867033456657","volume":"10","author":"J Arts","year":"2003","unstructured":"Arts J, De SS, Van EK (2003) Histone deacetylase inhibitors: from chromatin remodeling to experimental cancer therapeutics. Curr Med Chem 10(22):2343\u20132350","journal-title":"Curr Med Chem"},{"issue":"3","key":"3086_CR53","first-page":"277","volume":"53","author":"Z Shitikova","year":"2011","unstructured":"Shitikova Z, Aksenov ND, Pospelov VA, Pospelov TV (2011) Cell senescence induced by histone deacetylase inhibitor sodium butyrate in rodent transformed cells resistant to apoptosis. Tsitologiia 53(3):277\u2013284","journal-title":"Tsitologiia"},{"key":"3086_CR54","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.biochem.67.1.545","volume":"67","author":"JL Workman","year":"1998","unstructured":"Workman JL, Kingston RE (1998) Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 67:545\u2013579","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"3086_CR55","first-page":"296","volume":"2","author":"Y Li","year":"2010","unstructured":"Li Y, Zhang ZF, Chen J, Huang D, Ding Y, Tan MH et al (2010) VX680\/MK-0457, a potent and selective aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res 2(3):296\u2013308","journal-title":"Am J Transl Res"},{"issue":"(6A)","key":"3086_CR56","first-page":"4147","volume":"18","author":"B Desoize","year":"1998","unstructured":"Desoize B, Gimonet D, Jardiller JC (1998) Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res 18((6A)):4147\u20134158","journal-title":"Anticancer Res"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-012-3086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-012-3086-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-012-3086-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T02:24:18Z","timestamp":1642040658000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-012-3086-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["3086"],"URL":"https:\/\/doi.org\/10.1007\/s00383-012-3086-6","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}